EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research progress on NAT10-mediated acetylation in normal development and disease

Da Qin, Qing Liu, Xiaochao Ma, Rui Wang, Tianyu Lu, Yue Yang, Ze Tang, Yanbo Zhu

Frontiers in Cell and Developmental Biology · 13.08.2025 · 13

DOI: 10.3389/fcell.2025.1623276 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 13.08.2025. Verfasst von Da Qin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery II, Organ Transplantation Center, The First Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N4-acetylcytidine (ac4C) is an evolutionarily conserved RNA modification catalyzed by the acetyltransferase NAT10. It regulates RNA stability, translation, and post-transcriptional processes. Meanwhile, NAT10 functions as a dual-function enzyme exhibiting both protein acetyltransferase and RNA acetylase activities. This review summarizes the structural and functional roles of NAT10-mediated acetylation in physiological contexts, including cell division, differentiation, inflammation, aging, and viral infection, as well as its emerging roles in cancer. In malignancies, NAT10-mediated acetylation drives tumor progression by enhancing mRNA stability, regulating cell cycle, promoting metastasis, suppressing ferroptosis, modulating metabolism, influencing p53 activity, mediating immune escape and fostering drug resistance. Interactions between NAT10 and non-coding RNAs further amplify its oncogenic effects. Unresolved questions, such as microbiota-mediated ac4C regulation and NAT10’s impact on the tumor immune microenvironment, highlight future research directions. Targeting NAT10 and ac4C modification presents promising therapeutic opportunities, with advanced technologies like single-cell sequencing poised to refine epitranscriptome-based interventions.

Schlagwörter

Stichwörter der Autor:innen

AC4CNAT10RNA modificationcancerepitranscriptomicstherapeutic target

Autor:innen und Institutionen

  • Department of Thoracic Surgery II, Organ Transplantation Center, The First Hospital of Jilin University, Changchun, China.
  • Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, The First Hospital of Jilin University, Changchun, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Qin, D., Liu, Q., Ma, X., Wang, R., Lu, T., Yang, Y., Tang, Z., & Zhu, Y. (2025). Research progress on NAT10-mediated acetylation in normal development and disease. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1623276

Vancouver

Qin D, Liu Q, Ma X, Wang R, Lu T, Yang Y, et al. Research progress on NAT10-mediated acetylation in normal development and disease. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1623276

BibTeX
@article{Qin2025,
  author = {Qin, Da and Liu, Qing and Ma, Xiaochao and Wang, Rui and Lu, Tianyu and Yang, Yue and Tang, Ze and Zhu, Yanbo},
  title = {Research progress on NAT10-mediated acetylation in normal development and disease},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fcell.2025.1623276}
}
Kostenlos starten →